Home
DrugRxiv Drug Repurposing Network Medicine
REPO4EU Meet the team Drug Repurposing Research Collection Conference
Blog
Register Dashboard
Search
Home
DrugRxiv Drug Repurposing Network Medicine
REPO4EU Meet the team Drug Repurposing Research Collection Conference
My ScienceOpen

Register Dashboard
Search
294
views
4
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      218
      similar
       All similar
      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Repurposing benztropine as TB host directed therapy

      Published
      conference-abstract
      Author(s): 1 , 1 , 1 , 1
      Publication date (Electronic, pub):
      Publisher: REPO4EU
      Conference name: RExPO23
      Conference date: 25-26 October 2023
      Keywords: Benztropine, Host-directed-therapy, Tuberculosis, Histamine receptor, Infectious Diseases
      Bookmark

            Abstract

            Content

            Author and article information

            Conference
            Publisher: REPO4EU
            Publication date (Electronic, pub): 12 September 2023
            Affiliations
            [1 ] Departments of Medicine and Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, B.C. (Canada) ( https://ror.org/03rmrcq20)
            Article
            DOI: 10.58647/REXPO.23006
            SO-VID: 5ac54a36-0014-4931-89e8-2ca4b5c22673
            Copyright © Authors
            License:

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            Conference name: RExPO23
            Conference number: 2
            Conference location: Stockholm, Sweden
            Conference date: 25-26 October 2023
            History
            Product

            REPO4EU

            Categories

            Data availability: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            ScienceOpen disciplines: Pharmacology & Pharmaceutical medicine
            Keywords: Benztropine,Host-directed-therapy,Tuberculosis,Histamine receptor,Infectious Diseases

            References

            1. Chakaya Jeremiah, Petersen Eskild, Nantanda Rebecca, Mungai Brenda N., Migliori Giovanni Battista, Amanullah Farhana, Lungu Patrick, Ntoumi Francine, Kumarasamy Nagalingeswaran, Maeurer Markus, Zumla Alimuddin. The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB. International Journal of Infectious Diseases. Vol. 124:2022. Elsevier BV. [Cross Ref]

            2. Kilinç Gül, Saris Anno, Ottenhoff Tom H. M., Haks Mariëlle C.. Host‐directed therapy to combat mycobacterial infections*. Immunological Reviews. Vol. 301(1):62–83. 2021. Wiley. [Cross Ref]

            3. Baindara Piyush. Host-directed therapies to combat tuberculosis and associated non-communicable diseases. Microbial Pathogenesis. Vol. 130:156–168. 2019. Elsevier BV. [Cross Ref]

            4. Ahmed Sultan, Raqib Rubhana, Guðmundsson Guðmundur Hrafn, Bergman Peter, Agerberth Birgitta, Rekha Rokeya Sultana. Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation. Antibiotics. Vol. 9(1)2020. MDPI AG. [Cross Ref]

            Comments

            Comment on this article